Onwards and Upwards: Navigating the Future of Diabetes Care

Abstract

The escalating global prevalence of type 2 diabetes mellitus prompts a critical need for innovative approaches to its management. Managing T2DM presents  challenges, and the call for treatments targeting different pathways is paramount. Current antidiabetic drugs predominantly focus on glucose control, but the surge in T2DM cases necessitates newer agents that not only regulate glucose levels but also address the multifaceted aspects of the disease.
As the diabetes epidemic persists, exploring innovative therapeutic avenues becomes crucial for improved outcomes and a better quality of life for those grappling with this prevalent metabolic disorder. This editorial emphasizes newer targets, spotlighting novel agents regulating glucose levels and delaying disease progression.